Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
EWTX compared with CRVS: revenue, margins and what each company keeps, and the suppliers and customers both name
EWTX
Edgewise Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
CRVS
Corvus Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
EWTX
Edgewise Therapeutics, Inc.
vs
CRVS
Corvus Pharmaceuticals, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
EWTX
Edgewise Therapeutics, Inc.
Change
38.13
· pre 38.14
· delayed
Mkt cap
$4.2B
CRVS
Corvus Pharmaceuticals, Inc.
Change
9.70
· pre 9.76
· delayed
Pre-market
Nov 2 '26
delayed
Mkt cap
$816.0M
vs
Compare
Pre-market
Nov 2 '26
delayed
EWTX
Edgewise Therapeutics, Inc.
vs
CRVS
Corvus Pharmaceuticals, Inc.
38.13
pre 38.14
delayed
Price
9.70
pre 9.76
delayed
$4.2B
Mkt cap
$816.0M
Change
Change
EWTX
38.13
vs
CRVS
9.70
Pre-market
Nov 2 '26
delayed
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
EWTX, solid
CRVS, dashed
Supply-chain overlap
Revenue flow
EWTX: latest quarter not drawable. CRVS: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only EWTX
2
—
Leerink
unlisted
supplier
—
Silicon Valley Bank (SVB)
unlisted
supplier
Shared
0
No shared counterparties.
Only CRVS
1
—
Angel Pharmaceuticals
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR